In ASP4132, treated where ASP4132 is an AMPK activator in the NSCLC cells, AMPK downstream actions such as mTORC1 inhibition, PDGFR and EGFR degradation, Akt suppression, and autophagy activation were identified. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.